Lantheus (NASDAQ: LNTH)
Lantheus Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Lantheus Company Info
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and Puerto Rico, third-party distribution in Europe, Canada, Australia, Asia-Pacific, and Latin America, and the EXINI business in Sweden. The company was founded in 1956 and is headquartered in Bedford, MA.
News & Analysis
Why Lantheus Holdings Stock Won Big on Wednesday
Why Lantheus Holdings Stock Is Skyrocketing Today
Investors are cheering a proposed rule that could boost Lantheus' revenue.
Two Medical Imaging Stocks That Are Better Buys Than Nano-X
Both companies are using artificial intelligence to improve their products.
Why Shares of Lantheus Holdings Are Up Thursday
The company reported a record quarter for revenue.
Why Shares of Lantheus Holdings Rose This Week
The company's fourth-quarter and full-year earnings were a pleasant surprise.
These 3 No-Brainer Stocks Are Leading the Market This Quarter. Can You Still Buy?
Is it too late to buy these stocks that grew through the market correction?
Why Lantheus Holdings' Shares Are Up 16.4% Friday
A better-than-expected earnings report has investors buying.
Why Lantheus Holdings Stock Skyrocketed Today
That's what tends to happen when you trounce analyst revenue and profitability estimates.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.